Atellica® IM High-Sensitivity Troponin I (TnIH) Assay
Atellica IM High-Sensitivity Troponin I assay is first in the US to include Prognostic Risk as part of a new, expanded intended use claim
Reliable and accurate results
Analysis of troponin samples
My professional experience with Siemens confirms the effectiveness of the system use for analysis of troponin samples in an emergency situation. Overall the only limitation of the system was that the quality control stability can be interrupted if the instrument do not run high volume of samples ( the instrument is designed for high volume of samples) .
Review Date: 3 Sept 2023 | Siemens Healthineers
Disclaimer:
This claim applies to Atellica IM TnIH and is intended for U.S. audiences only
Distributed by Siemens Healthcare Diagnostics Inc. Product availability varies by country and cannot be guaranteed.
Product availability varies by country and is subject to varying regulatory requirements.
Please contact your local representative for availability.
Atellica and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.
High-sensitivity point-of-care cardiac troponin: Novel whole-blood testing at last
This webinar is also available with subtitles in Portuguese and Spanish.
In this expert webinar, Dr. Fred Apple discusses the relevance and use of high-sensitivity troponin in the emergency department setting. Dr. Apple reviews the scientific literature pertaining to high-sensitivity point-of-care (POC) troponin and speaks to the critical considerations for set-up and implementation of POC clinical studies, including the combined efforts of the laboratory and emergency department clinical staff.
- Explain the clinical utilization of high-sensitivity troponin as an aid in the diagnosis of acute myocardial infarction.
- Interpret the newest scientific data pertaining to novel POC high-sensitivity troponin.
- Summarize key insights around the collaborative process among the laboratory and emergency department clinical staff.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary for continuing education purposes.
CEU credits
Attendees of this webinar are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC.
The Atellica IM High-Sensitivity Troponin I assay expands capabilities in cardiac care
The first cleared troponin assay in the U.S. for longer-term prognostic insights
The Atellica IM TnIH test helps predict patient risk of cardiac events/death
This high-sensitivity troponin test from Siemens Healthineers is the only one in the US with a prognostic risk intended use






















